Terms: = Head and neck cancer AND LPP, Q93052, 4026, ENSG00000145012 AND Treatment
8 results:
1. LINC00092 Enhances lpp Expression to Repress Thyroid cancer Development via Sponging miR-542-3p.
Wang H
Horm Metab Res; 2024 Feb; 56(2):150-158. PubMed ID: 37935247
[TBL] [Abstract] [Full Text] [Related]
2. Germline findings in patients with advanced malignancies screened with paired blood-tumour testing for personalised treatment approaches.
Roggia C; Armeanu-Ebinger S; Gschwind A; Seibel-Kelemen O; Hertler S; Faust U; Liebmann A; Haack TB; Neumann M; Bonzheim I; Forschner A; Kopp HG; Herster F; Hartkopf A; Bitzer M; Malek NP; Brecht IB; Ruhm K; Möller Y; Löwenheim H; Ossowski S; Rieß OH; Schroeder C
Eur J Cancer; 2023 Jan; 179():48-55. PubMed ID: 36495689
[TBL] [Abstract] [Full Text] [Related]
3. Diagnostic efficacy of positron emission computerized tomography scans in suspicious laryngeal findings postorgan preservation treatment.
Warshavsky A; Holan A; Muhanna N; Oestraicher Y; Nachalon Y; Kampel L; Nard-Carmel N; Chaushu H; Shapira U; Ungar O; Gutfeld O; Ospovat I; Oz YN; Even-Sapir E; Horowitz G
Head Neck; 2023 Jan; 45(1):207-211. PubMed ID: 36301004
[TBL] [Abstract] [Full Text] [Related]
4. The Optimal Second-Line Systemic treatment Model for Recurrent and/or Metastatic head and neck Squamous Cell Carcinoma: A Bayesian Network Meta-Analysis.
Zhan ZJ; Yao WY; Zhang F; Qiu WZ; Liao K; Feng JH; Tan JY; Liu H; Yuan TZ; Zheng RH; Yuan YW
Front Immunol; 2021; 12():719650. PubMed ID: 34413862
[TBL] [Abstract] [Full Text] [Related]
5. Therapeutic Implications of Germline Testing in Patients With Advanced cancers.
Stadler ZK; Maio A; Chakravarty D; Kemel Y; Sheehan M; Salo-Mullen E; Tkachuk K; Fong CJ; Nguyen B; Erakky A; Cadoo K; Liu Y; Carlo MI; Latham A; Zhang H; Kundra R; Smith S; Galle J; Aghajanian C; Abu-Rustum N; Varghese A; O'Reilly EM; Morris M; Abida W; Walsh M; Drilon A; Jayakumaran G; Zehir A; Ladanyi M; Ceyhan-Birsoy O; Solit DB; Schultz N; Berger MF; Mandelker D; Diaz LA; Offit K; Robson ME
J Clin Oncol; 2021 Aug; 39(24):2698-2709. PubMed ID: 34133209
[TBL] [Abstract] [Full Text] [Related]
6. Forkhead box D1 promotes EMT and chemoresistance by upregulating lncRNA CYTOR in oral squamous cell carcinoma.
Chen S; Yang M; Wang C; Ouyang Y; Chen X; Bai J; Hu Y; Song M; Zhang S; Zhang Q
Cancer Lett; 2021 Apr; 503():43-53. PubMed ID: 33352248
[TBL] [Abstract] [Full Text] [Related]
7. Functional analysis of Zyxin in cell migration and invasive potential of oral squamous cell carcinoma cells.
Yamamura M; Noguchi K; Nakano Y; Segawa E; Zushi Y; Takaoka K; Kishimoto H; Hashimoto-Tamaoki T; Urade M
Int J Oncol; 2013 Mar; 42(3):873-80. PubMed ID: 23292068
[TBL] [Abstract] [Full Text] [Related]
8. Vocal fundamental frequency measures as a reflection of tumor response to chemotherapy in patients with advanced laryngeal cancer.
Orlikoff RF; Kraus DH; Harrison LB; Ho ML; Gartner CJ
J Voice; 1997 Mar; 11(1):33-9. PubMed ID: 9075174
[TBL] [Abstract] [Full Text] [Related]
